Dr. Kaitlin M. Dailey is Junior Faculty as a Research Instructor at the University of Nebraska Medical Center’s Eppley Institute for Research in Cancer and Allied Diseases in the Fred & Pamela Buffett Cancer Center. During her doctoral studies, she became fascinated with the many advantages oncolytic bacteria have over traditional therapeutics. As a result, she pursued specific training in genetic engineering and anaerobic bacteria. She performed ground-breaking studies, accomplishing the first CRISPR-mediated modification of Clostridium novyi-NT and established methodologies that have added to the field of biologic therapeutics. Dr. Kaitlin M. Dailey chose post-doctorate studies at UNMC to further her training in immunology, cancer models, bacterial genetics, and microbiology hosted by the labs of Dr. Michael A. (Tony) Hollingsworth (cancer biology, immunology) and Dr. Kenneth W. Bayles (bacterial genetics, microbiology). Her long-term career goal is to establish a diverse and equitable academic research lab focused on genetically engineering single celled organisms for pharmaceutical and biofuel development. Additionally, she ascribes to the teacher/scholar model and intends to use her expertise to generate graduate and undergraduate courses as well as to mentor students in a laboratory setting.